Posted On: 5/29/2020 9:39 AM
LAE201INT2101- A Phase1/2 Dose-Escalation and Efficacy Study of LAE001/prednisone plus Afuresertib.
MCRPC following SOC treatment.
Sponsored by: Laekna
Please contact one of our Clinical Research Coordinators today to find out more information if you are interested in this trial.
Research Department (315) 478-4185, option 3